Literature DB >> 7406373

Right and left ventricular exercise performance in chronic obstructive pulmonary disease: radionuclide assessment.

R A Matthay, H J Berger, R A Davies, J Loke, D A Mahler, A Gottschalk, B L Zaret.   

Abstract

Right and left ventricular pump performance was assessed at rest and during upright bicycle exercise in 30 patients with chronic obstructive pulmonary disease and in 25 normal control subjects. Right ventricular and left ventricular ejection fractions were ascertained noninvasively using first-pass quantitative radionuclide angiocardiography. The normal ventricular response to exercise was at least a 5% absolute increase in the ejection fraction of either ventricle. In patients the predominant cardiac abnormality involved performance of the right ventricle. Right ventricular ejection fraction was abnormal at rest in eight patients. Twenty-three patients demonstrated an abnormal right ventricular response to submaximal exercise. Airway obstruction and arterial hypoxemia were significantly more severe in patients with abnormal right ventricular exercise reserve than in those with normal reserve. Abnormal left ventricular performance was infrequent either at rest (four patients) or during exercise (six patients). Thus, this radionuclide technique allows noninvasive assessment of biventricular exercise reserve in chronic obstructive pulmonary disease.

Entities:  

Mesh:

Year:  1980        PMID: 7406373     DOI: 10.7326/0003-4819-93-2-234

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  22 in total

Review 1.  Should patients have cardiac catheterization prior to long-term oxygen treatment?

Authors:  W MacNee
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Noninvasive diagnosis of latent pulmonary hypertension in COPD by exercise-load impedance rheopneumogram: a comparative study with right heart catheterization.

Authors:  Y J Xu; S F Duan; Z X Zhang; G B Zen
Journal:  J Tongji Med Univ       Date:  1991

3.  My paper 20 years later: Effect of positive end-expiratory pressure on right ventricular function in humans.

Authors:  Michael R Pinsky
Journal:  Intensive Care Med       Date:  2014-04-24       Impact factor: 17.440

4.  Imagining guidelines for nuclear cardiology procedures. American Society of Nuclear Cardiology. Myocardial perfusion SPECT protocols.

Authors: 
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

Review 5.  Assessment of the right ventricle with radionuclide techniques.

Authors:  D S Schulman
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

Review 6.  The right ventricle under pressure: evaluating the adaptive and maladaptive changes in the right ventricle in pulmonary arterial hypertension using echocardiography (2013 Grover Conference series).

Authors:  Alexis Harrison; Nathan Hatton; John J Ryan
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

7.  Influence of respiratory variations on right ventricular function.

Authors:  J L Caplin; W D Flatman; L Dyke; M N Wiseman; D S Dymond
Journal:  Br Heart J       Date:  1989-10

8.  The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced emphysema.

Authors:  Yochai Adir; Jacob E Ollech; Baruch Vainshelboim; Yael Shostak; Arie Laor; Mordechai R Kramer
Journal:  Lung       Date:  2015-03-07       Impact factor: 2.584

9.  Influence of respiratory pressure support on hemodynamics and exercise tolerance in patients with COPD.

Authors:  Cristino Carneiro Oliveira; Cláudia Regina Carrascosa; Audrey Borghi-Silva; Danilo C Berton; Fernando Queiroga; Eloara M V Ferreira; Luiz E Nery; J Alberto Neder; J Alberto Neder
Journal:  Eur J Appl Physiol       Date:  2010-03-06       Impact factor: 3.078

10.  Assessment by radionuclide angiography of right and left ventricular function in chronic bronchitis and emphysema.

Authors:  W MacNee; Q F Xue; W J Hannan; D C Flenley; C J Adie; A L Muir
Journal:  Thorax       Date:  1983-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.